Journal of Thoracic Oncology

SJR Rank #148H-index: 204SJR: 7.497Best quartile: Q1APC: US$4,100
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202502468

Subject Categories

  • Medicine (miscellaneous)Q1
  • OncologyQ1
  • Pulmonary and Respiratory MedicineQ1

Areas: Medicine

Most published research topics

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical ImagingCancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesGastric Cancer Management and OutcomesCancer Diagnosis and TreatmentOccupational and environmental lung diseases

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025080160240320

Detailed Information

ISSN

1556-1380, 1556-0864

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

7.54

References per Document

24.07

Coverage

2006-2026

Scope

Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.

Metrics from SCImago Journal Rank 2025. View on SCImago